143 related articles for article (PubMed ID: 27607158)
1. Incidental Finding of Cerebellar Medulloblastoma on 68Ga-DOTATATE PET/CT in a Patient With Appendiceal Carcinoid.
Chan M; Hsiao E
Clin Nucl Med; 2016 Nov; 41(11):886-887. PubMed ID: 27607158
[TBL] [Abstract][Full Text] [Related]
2. Multifocal Small Bowel Carcinoid: Evaluation by 68Ga-DOTATATE PET.
Clark M; Nathan M; Broski SM
Clin Nucl Med; 2019 Apr; 44(4):e308-e310. PubMed ID: 30762820
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTANOC PET/CT in Medulloblastoma.
Arunraj ST; Parida GK; Damle NA; Arora S; Reddy S; Chakraborty D; Prabhu M; Tripathi M; Bal C
Clin Nucl Med; 2018 May; 43(5):e145-e146. PubMed ID: 29485447
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis Circumscripta on 68Ga-DOTATATE PET CT.
Gandy N; Ordidge KL; Arshad M; Win Z
Clin Nucl Med; 2019 Jun; 44(6):e404-e405. PubMed ID: 30985430
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC
J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865
[TBL] [Abstract][Full Text] [Related]
6. Distinct Imaging Characteristics of Different Metastases From Primary Prostate Adenocarcinoma and Rectal Carcinoid Tumor on 18F-Fluciclovine and 68Ga-DOTATATE PET/CT.
Bosserman AJ; Dai D; Lu Y
Clin Nucl Med; 2019 Jan; 44(1):83-84. PubMed ID: 30371597
[TBL] [Abstract][Full Text] [Related]
7. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites.
Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E
J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Medulloblastoma: 18F-FDG and 68Ga-DOTANOC PET/CT in Response Evaluation.
ArunRaj ST; Kumar A; Kp H; Mohan N; Gupta S; Tripathi M; Bal C
Clin Nucl Med; 2021 May; 46(5):e262-e263. PubMed ID: 33315670
[TBL] [Abstract][Full Text] [Related]
9. 68Ga-DOTATATE PET/CT of Ectopic Cushing Syndrome Due to Appendicular Carcinoid.
Diwaker C; Shah RK; Patil V; Jadhav S; Lila A; Bandgar T; Shah N
Clin Nucl Med; 2019 Nov; 44(11):881-882. PubMed ID: 31524683
[TBL] [Abstract][Full Text] [Related]
10. Adolescent With 68Ga DOTATATE-Avid Vertebral Hemangioma Mimicking Metastasis in PET Imaging.
Skoura E; Alshammari A; Syed R; Sajjan R; Bomanji J
Clin Nucl Med; 2015 Jul; 40(7):e378-9. PubMed ID: 25783517
[TBL] [Abstract][Full Text] [Related]
11. 68Ga DOTATATE PET/CT Versus 18F-FDG PET/CT for Detecting Intramedullary Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.
Banezhad F; Kiamanesh Z; Emami F; Sadeghi R
Clin Nucl Med; 2019 Jun; 44(6):e385-e387. PubMed ID: 30985433
[TBL] [Abstract][Full Text] [Related]
12. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
14. Incidental Uptake in Benign Gynecomastia on 68Ga-DOTATATE PET/CT.
Pandika V; Covington MF
Clin Nucl Med; 2019 Oct; 44(10):799-800. PubMed ID: 30985420
[TBL] [Abstract][Full Text] [Related]
15. Incidental Detection of Medullary Thyroid Carcinoma by 68Ga-DOTATATE PET/CT in a Patient With Neuroendocrine Tumor Liver Metastases.
Mahajan S; Shaha A; Grewal RK
Clin Nucl Med; 2018 Feb; 43(2):136-138. PubMed ID: 29261627
[TBL] [Abstract][Full Text] [Related]
16. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
17. Value of the
Fastrez M; Artigas C; Sirtaine N; Wimana Z; Caillet M; Rozenberg S; Flamen P
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():69-74. PubMed ID: 28342392
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.
Kunikowska J; Lewington V; Krolicki L
Clin Nucl Med; 2017 Dec; 42(12):905-911. PubMed ID: 29076910
[TBL] [Abstract][Full Text] [Related]
19. Carcinoid tumors of the appendix: are these tumors identifiable prospectively on preoperative CT?
Coursey CA; Nelson RC; Moreno RD; Dodd LG; Patel MB; Vaslef S
Am Surg; 2010 Mar; 76(3):273-5. PubMed ID: 20349655
[TBL] [Abstract][Full Text] [Related]
20. PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
Yakemchuk VN; Jager PL; Chirakal R; Reid R; Major P; Gulenchyn KY
Nucl Med Commun; 2012 Mar; 33(3):322-30. PubMed ID: 22183015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
